Evidence map›Paper›PMID 27984530›Full record

ArticlePain2017

Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint.

Nicolas Kerckhove, Bruno Pereira, Denis Pezet, David Balayssac

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Pain, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Analgesic efficacy of non-invasive neuromodulation techniques in chronic cancer pain: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  2. Trial
  3. Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  4. Article
  5. Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Nicolas KerckhoveUniversité Clermont Auvergne, Inserm, U1107, NEURO-DOL, CHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France.
Bruno PereiraCHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France.
Denis PezetUniversité Clermont Auvergne, Inserm, U1071, USC INRA 2018, M2iSH, CHU Clermont-Ferrand, service de chirurgie et oncologie digestive, Clermont-Ferrand, France.
David BalayssacUniversité Clermont Auvergne, Inserm, U1107, NEURO-DOL, CHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PainAntineoplastic AgentsHumansPeripheral Nervous System DiseasesAntineoplastic Agents

Identifiers

PMID27984530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.